Tag: CGuard
“Incredible results”: C-GUARDIANS II data point to safety and efficacy of...
New findings from the C-GUARDIANS II study indicate that the CGuard Prime carotid stent system (InspireMD) achieves high procedural success, durable early luminal restoration,...
CGuard Prime carotid stent gains US and European approvals for stroke...
InspireMD has been granted premarket approval (PMA) from the US Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the...
InspireMD congratulates CREST-2 investigators on completion of trial enrolment
InspireMD today congratulated the lead investigators on the completion of enrolment in the CREST-2 clinical trials.
The CGuard embolic prevention stent system (EPS), utilising...
SIBERIA trial: Positive one-month results for embolic prevention system
InspireMD has announced positive interim results from the SIBERIA trial, an investigator-initiated study of the CGuard embolic prevention system (EPS). The data were presented...
Low embolisation risk with micromesh carotid stents
Patients treated with either the Roadsaver (Terumo) or the CGuard (InspireMD) micromesh carotid stents had similar low risk of embolisation following carotid artery stenting...
